Skip to content

The Effect of Bone-void Filler on Anterior Knee Pain Following ACL Reconstruction

The Effect of Bone-void Filler on Anterior Knee Pain Following ACL Reconstruction With Bone-Patellar Tendon Bone Autograft

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04533880
Enrollment
150
Registered
2020-09-01
Start date
2020-08-31
Completion date
2023-07-07
Last updated
2024-08-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

ACL

Brief summary

One of the common complaints after ACLR with BPTB autograft anterior knee pain. It is thought that this may be due to harvesting the patellar tendon for graft use. Specifically, this may be due to the bone defect that is left after graft harvesting. There is currently no consensus on a gold standard for treating the bone defect with surgeons using multiple commercially available bone void fillers as well as autologous bone graft in standard practice. The purpose of the proposed study is to evaluate the effect bone-void filler on anterior knee pain following ACL reconstruction BPTB autograft.

Interventions

DEVICEDBM

Demineralized bone matrix (Allosync, CDMB Putty, Arthrex, Naples, FL)

DEVICECalcium phosphate cement

Quickset, Arthrex, Naples, FL

Autologous bone grafting involves utilizing bone obtained from the same individual receiving the graft

Sponsors

NYU Langone Health
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Patients undergoing ACLR with BPTB autograft * Skeletally mature (as defined by closed growth plates on plain radiograph) * At least 18 years of age * Willing and able to provide consent

Exclusion criteria

* knee with intact ACL * skeletally immature (as defined by open physis on plain radiograph) * pregnant * less than 18 years of age * previous ACL repair or reconstruction * unable to speak english or perform informed consent * multiligamentous knee injury (two or more ligaments requiring surgical attention) * varus or valgus malalignment greater than 3 degrees

Design outcomes

Primary

MeasureTime frameDescription
Score on Knee Injury and Osteoarthritis Outcome Score (KOOS) SurveyMonth 12 Post-OpThe KOOS survery comprises 42 questions; questions are divided into 5 sub-categories: symptoms (7 questions), pain (9 questions), function/daily living (17 questions), function/sports and recreational activities (5 questions), quality of life (4 questions). Each item is rated on a Likert scale from 0 to 4. The score is calculated by summing the responses. The total range for each sub-category is 0-100, making the total range for the whole survey 0-500. The higher the score, the worse the symptoms and pain / higher difficulty in function.
Score on Kujala Anterior Knee Pain Scale (AKPS)Month 12 Post-OpThe Kujala AKPS is a 13-item screening instrument designed to assess patellofemoral pain in adolescents and young adults, with a variable ordinal response format. The total score is the sum of responses; total scores range from 0 to 100. Lower scores indicate greater signs of knee pain.
Change in VAS Score for Anterior Knee PainBaseline, Month 12 Post-OpThe visual analog scale (VAS) is a validated, subjective measure for acute and chronic pain. Scores are recorded by making a handwritten mark on a 10-cm line that represents a continuum between no pain and worst pain. The total score range is 0-100; the higher the score, the worse the pain.

Countries

United States

Participant flow

Participants by arm

ArmCount
Control
The control group will receive autologous bone obtained from the BTBPB graft harvest Autologous bone graft: Autologous bone grafting involves utilizing bone obtained from the same individual receiving the graft
52
Autologous Bone + DBM
Autologous bone plus demineralized bone matrix DBM: Demineralized bone matrix (Allosync, CDMB Putty, Arthrex, Naples, FL) Autologous bone graft: Autologous bone grafting involves utilizing bone obtained from the same individual receiving the graft
49
Autologous Bone + Calcium Phosphate Cement
Autologous bone plus calcium phosphate cement Calcium phosphate cement: Quickset, Arthrex, Naples, FL Autologous bone graft: Autologous bone grafting involves utilizing bone obtained from the same individual receiving the graft
47
Total148

Withdrawals & dropouts

PeriodReasonFG000FG001FG002
Overall StudyLost to Follow-up011

Baseline characteristics

CharacteristicControlTotalAutologous Bone + Calcium Phosphate CementAutologous Bone + DBM
Age, Continuous27.7 years
STANDARD_DEVIATION 6.8
28.43 years
STANDARD_DEVIATION 7.13
28.8 years
STANDARD_DEVIATION 6.5
28.8 years
STANDARD_DEVIATION 8.1
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants0 Participants0 Participants0 Participants
Race (NIH/OMB)
Asian
0 Participants0 Participants0 Participants0 Participants
Race (NIH/OMB)
Black or African American
0 Participants0 Participants0 Participants0 Participants
Race (NIH/OMB)
More than one race
0 Participants0 Participants0 Participants0 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants0 Participants0 Participants0 Participants
Race (NIH/OMB)
Unknown or Not Reported
52 Participants148 Participants47 Participants49 Participants
Race (NIH/OMB)
White
0 Participants0 Participants0 Participants0 Participants
Region of Enrollment
United States
52 participants148 participants47 participants49 participants
Sex: Female, Male
Female
18 Participants71 Participants27 Participants26 Participants
Sex: Female, Male
Male
34 Participants77 Participants20 Participants23 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
EG002
affected / at risk
deaths
Total, all-cause mortality
0 / 520 / 490 / 47
other
Total, other adverse events
0 / 520 / 490 / 47
serious
Total, serious adverse events
0 / 520 / 490 / 47

Outcome results

Primary

Change in VAS Score for Anterior Knee Pain

The visual analog scale (VAS) is a validated, subjective measure for acute and chronic pain. Scores are recorded by making a handwritten mark on a 10-cm line that represents a continuum between no pain and worst pain. The total score range is 0-100; the higher the score, the worse the pain.

Time frame: Baseline, Month 12 Post-Op

ArmMeasureValue (MEAN)Dispersion
ControlChange in VAS Score for Anterior Knee Pain-5.5 score on a scaleStandard Deviation 24.3
Autologous Bone + DBMChange in VAS Score for Anterior Knee Pain-8.4 score on a scaleStandard Deviation 26.9
Autologous Bone + Calcium Phosphate CementChange in VAS Score for Anterior Knee Pain1 score on a scaleStandard Deviation 26.4
Primary

Score on Knee Injury and Osteoarthritis Outcome Score (KOOS) Survey

The KOOS survery comprises 42 questions; questions are divided into 5 sub-categories: symptoms (7 questions), pain (9 questions), function/daily living (17 questions), function/sports and recreational activities (5 questions), quality of life (4 questions). Each item is rated on a Likert scale from 0 to 4. The score is calculated by summing the responses. The total range for each sub-category is 0-100, making the total range for the whole survey 0-500. The higher the score, the worse the symptoms and pain / higher difficulty in function.

Time frame: Month 12 Post-Op

ArmMeasureValue (MEAN)Dispersion
ControlScore on Knee Injury and Osteoarthritis Outcome Score (KOOS) Survey67 score on a scaleStandard Deviation 6.1
Autologous Bone + DBMScore on Knee Injury and Osteoarthritis Outcome Score (KOOS) Survey69 score on a scaleStandard Deviation 6.3
Autologous Bone + Calcium Phosphate CementScore on Knee Injury and Osteoarthritis Outcome Score (KOOS) Survey67.7 score on a scaleStandard Deviation 8.2
Primary

Score on Kujala Anterior Knee Pain Scale (AKPS)

The Kujala AKPS is a 13-item screening instrument designed to assess patellofemoral pain in adolescents and young adults, with a variable ordinal response format. The total score is the sum of responses; total scores range from 0 to 100. Lower scores indicate greater signs of knee pain.

Time frame: Month 12 Post-Op

ArmMeasureValue (MEAN)Dispersion
ControlScore on Kujala Anterior Knee Pain Scale (AKPS)87.1 score on a scaleStandard Deviation 11
Autologous Bone + DBMScore on Kujala Anterior Knee Pain Scale (AKPS)85.7 score on a scaleStandard Deviation 17
Autologous Bone + Calcium Phosphate CementScore on Kujala Anterior Knee Pain Scale (AKPS)86.2 score on a scaleStandard Deviation 12.1

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026